Combination Immunosuppressive Therapy Including Rituximab for Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in Adult-Onset Still’s Disease
Hemophagocytic lymphopcytosis (HLH) is a life-threatening condition. It can occur either as primary form with genetic defects or secondary to other conditions, such as hematological or autoimmune diseases. Certain triggering factors can predispose individuals to the development of HLH. We report the...
Saved in:
| Main Authors: | Eva Johanna Schäfer, Wolfram Jung, Peter Korsten |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Case Reports in Rheumatology |
| Online Access: | http://dx.doi.org/10.1155/2016/8605274 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Onset of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis triggered by sudden reactivation of asymptomatic latent Epstein-Barr virus infection
by: Masanari Mizuki, et al.
Published: (2025-07-01) -
Hemophagocytic lymphohistiocytosis Secondary to Epstein–Barr Virus presenting as Rhabdomyolysis
by: Zachary Holtzapple, et al.
Published: (2025-06-01) -
Alternative Therapy for Epstein-Barr Virus Related Hemophagocytic Lymphohistiocytosis
by: Omar Al Asad, et al.
Published: (2015-01-01) -
A predictive model for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis
by: Rui Huang, et al.
Published: (2024-12-01) -
Adult-Onset Still's Disease Masquerading as Hemophagocytic Lymphohistiocytosis
by: Pooja Gautam, et al.
Published: (2021-07-01)